Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CoreCard Corporation
  6. Summary
    CCRD   US45816D1000

CORECARD CORPORATION

(CCRD)
  Report
Delayed Nyse  -  04:09 2022-08-12 pm EDT
24.80 USD   -0.40%
08/12WeTrade Group Agrees to Sell Monkeypox Virus Test Kits to Parkway Medical; Shares Rise
MT
08/12WeTrade Group Agrees to Sell Monkeypox Virus Test Kits to Parkway Medical
MT
08/03TRANSCRIPT : CoreCard Corporation, Q2 2022 Earnings Call, Aug 03, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
25.16(c) 25.47(c) 24.8(c) 24.9(c) 24.8(c) Last
89 100 49 171 24 864 26 711 16 955 Volume
+0.20% +1.23% -2.63% +0.40% -0.40% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 66,9 M - -
Net income 2022 15,4 M - -
Net cash position 2022 23,6 M - -
P/E ratio 2022 13,9x
Yield 2022 -
Sales 2023 69,7 M - -
Net income 2023 17,8 M - -
Net cash position 2023 42,0 M - -
P/E ratio 2023 12,0x
Yield 2023 -
Capitalization 212 M 212 M -
EV / Sales 2022 2,82x
EV / Sales 2023 2,45x
Nbr of Employees 800
Free-Float 68,2%
More Financials
Company
CoreCard Corporation is engaged in the business of providing card management platform built for the global transactions in a digital world. The Company designs, develops and markets a range of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay... 
Read more
More about the company
Ratings of CoreCard Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CORECARD CORPORATION
08/12WeTrade Group Agrees to Sell Monkeypox Virus Test Kits to Parkway Medical; Shares Rise
MT
08/12WeTrade Group Agrees to Sell Monkeypox Virus Test Kits to Parkway Medical
MT
08/03TRANSCRIPT : CoreCard Corporation, Q2 2022 Earnings Call, Aug 03, 2022
CI
08/03CORECARD : Reports Second Quarter 2022 Results - Form 8-K
PU
08/03CORECARD CORP Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/03CoreCard Corporation Reports Second Quarter 2022 Results
GL
08/03Earnings Flash (CCRD) CORECARD CORPORATION Posts Q2 Revenue $15.2M
MT
08/03CoreCard Corporation Reports Earnings Results for the Second Quarter and Six Months End..
CI
08/03CoreCard Corporation Reports Second Quarter 2022 Results
AQ
08/03CoreCard Corporation Provides Earnings Guidance for the Year 2022
CI
07/25CoreCard Corporation Schedules Second Quarter 2022 Earnings Release and Conference Call
GL
07/25CoreCard Corporation Schedules Second Quarter 2022 Earnings Release and Conference Call
AQ
07/21CoreCard to Participate in Upcoming Investor Conferences in August 2022
GL
07/21CoreCard to Participate in Upcoming Investor Conferences in August 2022
GL
06/24CORECARD CORPORATION(NYSE : CCRD) dropped from Russell 2500 Index
CI
More news
News in other languages on CORECARD CORPORATION
08/12WeTrade Group accepte de vendre les kits de test du virus Monkeypox à Parkway Medical ;..
08/12WeTrade Group accepte de vendre des kits de test du virus Monkeypox à Parkway Medical
08/03Earnings Flash (CCRD) CORECARD CORPORATION affiche un chiffre d'affaires de 15,2 millio..
08/03CoreCard Corporation annonce ses résultats financiers pour le deuxième trimestre et le ..
08/03CoreCard Corporation fournit des prévisions de bénéfices pour l'année 2022
More news
Chart CORECARD CORPORATION
Duration : Period :
CoreCard Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CORECARD CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 24,80 $
Average target price 54,00 $
Spread / Average Target 118%
EPS Revisions
Managers and Directors
James Leland Strange Chairman, President & Chief Executive Officer
Matthew A. White Chief Financial Officer, Secretary & VP
Philip H. Moise Independent Director
A. Russell Chandler Independent Director
Elizabeth W. Camp Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CORECARD CORPORATION-36.08%212
INTUIT INC.-24.34%137 276
FIDELITY NATIONAL INFORMATION SERVICES, INC.-6.44%62 087
ADYEN N.V.-20.13%58 625
WORLDLINE-8.96%12 860
AFFIRM HOLDINGS, INC.-61.03%11 225